Impellam Group PLC is a staffing & employment services business based in the UK. Impellam Group shares (IPEL.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Impellam Group employs 2,800 staff and has a trailing 12-month revenue of around £2.1 billion.
|Latest market close||N/Ap|
|52-week range||210p - 358.5p|
|50-day moving average||243.2059p|
|200-day moving average||239.8028p|
|Wall St. target price||950p|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||11.2p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Impellam Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Impellam Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Impellam Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Impellam Group shares trade at around 24x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Impellam Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £15.9 million.
The EBITDA is a measure of a Impellam Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£2.1 billion|
|Operating margin TTM||0.24%|
|Gross profit TTM||£274.1 million|
|Return on assets TTM||0.32%|
|Return on equity TTM||-10.87%|
|Market capitalisation||£117.1 million|
TTM: trailing 12 months
We're not expecting Impellam Group to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Impellam Group's shares have ranged in value from as little as 210p up to 358.5p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Impellam Group's is 0.3606. This would suggest that Impellam Group's shares are less volatile than average (for this exchange).
Impellam Group Plc provides staffing, human capital management, and outsourced people-related services in the United Kingdom, Ireland, North America, mainland Europe, Australasia, New Zealand, Singapore, and the Middle East. It operates through Global Talent Acquisition and Managed Workforce Solutions; Global Specialist Staffing; Regional Specialist Staffing; and Healthcare segments. The Global Talent Acquisition and Managed Workforce Solutions segment offers managed service programs, professional services solution, recruitment outsourcing programmes (RPO), contingent RPO, and direct sourcing models and adaptive services under the Comensura and Guidant Global brand names. The Global Specialist Staffing segment provides specialist staffing services to recruit scientific, clinical, technology, telecommunications, and digital specialists under the Lorien, onezeero, s.com, and SRG brand names. The Regional Specialist Staffing segment offers staffing services for technicians, secretaries, call center operatives, mechanical and product engineers, IT specialists, lawyers, teachers, aviation, and chefs under the Blue Arrow, Tate, Carbon60, Celsian, Career Teachers, Flexy, Chadwick Nott, Bartech Staffing, and Corestaf brands. The Healthcare segment provides healthcare workforce solutions, including healthcare staffing, managed services, staff bank, occupational health, social care, and home care services, as well as eHealth solutions under the Medacs Healthcare, Global Medics, Doctors on Call, Fast Response Healthcare, Litmus Workforce Solutions, and ignosys brand names. This segment also recruits temporary and permanent doctors, nurses and, allied health professionals. The company was incorporated in 2008 and is based in Luton, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.